Tin tức & Cập nhật

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

08 Feb 2022 bởi

The presence of appendicolith is tied to an almost twofold risk of requiring an appendectomy within 30 days in patients who initially received antibiotic therapy for acute uncomplicated appendicitis, according to an analysis of the CODA* study from the US.

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

08 Feb 2022

Probiotic use in IBD: Yay or nay?

08 Feb 2022 bởi

Using the probiotic Escherichia coli Nissle 1917 (EcN) as add-on therapy for patients with mild-to-moderate ulcerative colitis (UC) helps induce disease remission and preserve quality of life (QoL) in these patients, according to studies presented at CCC 2022.

Probiotic use in IBD: Yay or nay?

08 Feb 2022

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

08 Feb 2022

The COVID-19 pandemic has contributed to self-reported increases in psychological distress and gastrointestinal symptoms among individuals with irritable bowel syndrome (IBS) and comorbid anxiety and/or depression, reveals a study.

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

08 Feb 2022

Serological tests highly accurate for coeliac disease diagnosis

08 Feb 2022

Serological tests can reliably detect coeliac disease in children and adults, with the sensitivity of anti-tissue transglutaminase (tTG) being sufficient to rule out the disease while the high specificity of endomysial antibody (EMA) being useful for ruling in a diagnosis of the disease, according to the results of a systematic review and meta-analysis.

Serological tests highly accurate for coeliac disease diagnosis

08 Feb 2022

Adjuvant S-1 ups survival in resected biliary tract cancer

05 Feb 2022 bởi

Giving adjuvant S-1 to patients with curatively resected biliary tract cancer (BTC) significantly improves survival compared with observation following surgery, according to the ASCOT trial presented in the 2022 ASCO Gastrointestinal Cancers Symposium (GICS).

Adjuvant S-1 ups survival in resected biliary tract cancer

05 Feb 2022

Acupuncture bests pharmacotherapy for relieving depression, anxiety in FGID patients

05 Feb 2022

Acupuncture seems to be better than pharmacotherapy at relieving emotional symptoms in patients with functional gastrointestinal disorders (FGIDs), reports a recent meta-analysis.

Acupuncture bests pharmacotherapy for relieving depression, anxiety in FGID patients

05 Feb 2022

Immunomodulator withdrawal not linked to loss of response in IBD

02 Feb 2022

Among inflammatory bowel disease (IBD) patients, the discontinuation of immunomodulator treatment does not contribute to the risk of loss of response although it may lead to an increase in antidrug antibodies, according to a study.

Immunomodulator withdrawal not linked to loss of response in IBD

02 Feb 2022

Plecanatide may be safely administered with antacid

31 Jan 2022 bởi

Acid suppression therapy appears to exert no meaningful effect on the efficacy or safety of plecanatide when administered concomitantly, according to a study.

Plecanatide may be safely administered with antacid

31 Jan 2022

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

31 Jan 2022 bởi

The addition of postoperative radiotherapy (PORT) or postoperative concurrent chemoradiotherapy (POCRT) to surgery led to significant improvements in disease-free survival (DFS) and overall survival (OS) in individuals with pathological stage IIB-III oesophageal squamous cell carcinoma (SCC) compared with surgery alone, a prospective phase III study from China suggests.

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

31 Jan 2022

Real-world data reflect promising efficacy, safety of ozanimod for UC

30 Jan 2022 bởi

The first-in-class sphingosine-1-phosphate receptor modulator ozanimod showed promising efficacy and safety in a relatively treatment-refractory cohort of patients with ulcerative colitis (UC), according to the initial results of a prospective, observational cohort study presented at the Crohn’s and Colitis Congress 2022.

Real-world data reflect promising efficacy, safety of ozanimod for UC

30 Jan 2022

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

Appendicolith ups appendectomy risk after antibiotic treatment for acute appendicitis

Probiotic use in IBD: Yay or nay?

Probiotic use in IBD: Yay or nay?

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

Pandemic fuels mental distress, gastric problems in IBS patients with anxiety/depression

Serological tests highly accurate for coeliac disease diagnosis

Serological tests highly accurate for coeliac disease diagnosis

Adjuvant S-1 ups survival in resected biliary tract cancer

Adjuvant S-1 ups survival in resected biliary tract cancer

Acupuncture bests pharmacotherapy for relieving depression, anxiety in FGID patients

Acupuncture bests pharmacotherapy for relieving depression, anxiety in FGID patients

Immunomodulator withdrawal not linked to loss of response in IBD

Immunomodulator withdrawal not linked to loss of response in IBD

Plecanatide may be safely administered with antacid

Plecanatide may be safely administered with antacid

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

Postop adjuvant treatment yields survival benefit for stage IIB-III oesophageal SCC

Real-world data reflect promising efficacy, safety of ozanimod for UC

Real-world data reflect promising efficacy, safety of ozanimod for UC